AI Science Tracker
EN

Predicting Central Serous Chorioretinopathy Recurrence Using Machine Learning

Affiliation not stated in the reviewed material · 25 Nov 2021 · medicine

Discovery

Predicting Central Serous Chorioretinopathy Recurrence Using Machine Learning

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning models predict recurrence of central serous chorioretinopathy after laser treatment; the paper reports internal and external test-set accuracy and identifies clinical recurrence predictors. This is retrospective recurrence prediction, not evidence that model-guided care reduces recurrence. Internal and external test cohorts are described and Table 2 reports recurrence performance.

Technology: Supervised ML classifiers predict recurrence from clinical/ophthalmic variables.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Supervised ML classifiers predict recurrence from clinical/ophthalmic variables.
Test and result
Machine-learning models predict recurrence of central serous chorioretinopathy after laser treatment; the paper reports internal and external test-set accuracy and identifies clinical recurrence predictors. This is retrospective recurrence prediction, not evidence that model-guided care reduces recurrence.
Limitation / still unknown
Internal and external test cohorts are described and Table 2 reports recurrence performance. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.649316/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.